These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 24217791

  • 1. Aberrant expression of plastin-3 via copy number gain induces the epithelial-mesenchymal transition in circulating colorectal cancer cells.
    Sugimachi K, Yokobori T, Iinuma H, Ueda M, Ueo H, Shinden Y, Eguchi H, Sudo T, Suzuki A, Maehara Y, Mori M, Mimori K.
    Ann Surg Oncol; 2014 Oct; 21(11):3680-90. PubMed ID: 24217791
    [Abstract] [Full Text] [Related]

  • 2. Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis.
    Yokobori T, Iinuma H, Shimamura T, Imoto S, Sugimachi K, Ishii H, Iwatsuki M, Ota D, Ohkuma M, Iwaya T, Nishida N, Kogo R, Sudo T, Tanaka F, Shibata K, Toh H, Sato T, Barnard GF, Fukagawa T, Yamamoto S, Nakanishi H, Sasaki S, Miyano S, Watanabe T, Kuwano H, Mimori K, Pantel K, Mori M.
    Cancer Res; 2013 Apr 01; 73(7):2059-69. PubMed ID: 23378342
    [Abstract] [Full Text] [Related]

  • 3. Tumor-derived tenascin-C promotes the epithelial-mesenchymal transition in colorectal cancer cells.
    Takahashi Y, Sawada G, Kurashige J, Matsumura T, Uchi R, Ueo H, Ishibashi M, Takano Y, Akiyoshi S, Iwaya T, Eguchi H, Sudo T, Sugimachi K, Yamamoto H, Doki Y, Mori M, Mimori K.
    Anticancer Res; 2013 May 01; 33(5):1927-34. PubMed ID: 23645740
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. GATA6 predicts prognosis and hepatic metastasis of colorectal cancer.
    Shen F, Li J, Cai W, Zhu G, Gu W, Jia L, Xu B.
    Oncol Rep; 2013 Sep 01; 30(3):1355-61. PubMed ID: 23784465
    [Abstract] [Full Text] [Related]

  • 7. Overexpression of RhoGDI2 correlates with tumor progression and poor prognosis in colorectal carcinoma.
    Li X, Wang J, Zhang X, Zeng Y, Liang L, Ding Y.
    Ann Surg Oncol; 2012 Jan 01; 19(1):145-53. PubMed ID: 21861235
    [Abstract] [Full Text] [Related]

  • 8. The rs6983267 SNP is associated with MYC transcription efficiency, which promotes progression and worsens prognosis of colorectal cancer.
    Takatsuno Y, Mimori K, Yamamoto K, Sato T, Niida A, Inoue H, Imoto S, Kawano S, Yamaguchi R, Toh H, Iinuma H, Ishimaru S, Ishii H, Suzuki S, Tokudome S, Watanabe M, Tanaka J, Kudo SE, Mochizuki H, Kusunoki M, Yamada K, Shimada Y, Moriya Y, Miyano S, Sugihara K, Mori M.
    Ann Surg Oncol; 2013 Apr 01; 20(4):1395-402. PubMed ID: 22976378
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Overexpression of Transcription Termination Factor 1 is Associated with a Poor Prognosis in Patients with Colorectal Cancer.
    Ueda M, Iguchi T, Nambara S, Saito T, Komatsu H, Sakimura S, Hirata H, Uchi R, Takano Y, Shinden Y, Eguchi H, Masuda T, Sugimachi K, Yamamoto H, Doki Y, Mori M, Mimori K.
    Ann Surg Oncol; 2015 Dec 01; 22 Suppl 3():S1490-8. PubMed ID: 26036188
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Overexpression of ZEB2 at the invasion front of colorectal cancer is an independent prognostic marker and regulates tumor invasion in vitro.
    Kahlert C, Lahes S, Radhakrishnan P, Dutta S, Mogler C, Herpel E, Brand K, Steinert G, Schneider M, Mollenhauer M, Reissfelder C, Klupp F, Fritzmann J, Wunder C, Benner A, Kloor M, Huth C, Contin P, Ulrich A, Koch M, Weitz J.
    Clin Cancer Res; 2011 Dec 15; 17(24):7654-63. PubMed ID: 22042972
    [Abstract] [Full Text] [Related]

  • 15. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
    Meng X, Wu J, Pan C, Wang H, Ying X, Zhou Y, Yu H, Zuo Y, Pan Z, Liu RY, Huang W.
    Gastroenterology; 2013 Aug 15; 145(2):426-36.e1-6. PubMed ID: 23583431
    [Abstract] [Full Text] [Related]

  • 16. Microarray analysis reveals that high mobility group A1 is involved in colorectal cancer metastasis.
    Takahashi Y, Sawada G, Sato T, Kurashige J, Mima K, Matsumura T, Uchi R, Ueo H, Ishibashi M, Takano Y, Akiyoshi S, Eguchi H, Sudo T, Sugimachi K, Tanaka J, Kudo SE, Doki Y, Mori M, Mimori K.
    Oncol Rep; 2013 Sep 15; 30(3):1488-96. PubMed ID: 23835740
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Up-regulation of NEK2 by microRNA-128 methylation is associated with poor prognosis in colorectal cancer.
    Takahashi Y, Iwaya T, Sawada G, Kurashige J, Matsumura T, Uchi R, Ueo H, Takano Y, Eguchi H, Sudo T, Sugimachi K, Yamamoto H, Doki Y, Mori M, Mimori K.
    Ann Surg Oncol; 2014 Jan 15; 21(1):205-12. PubMed ID: 24046120
    [Abstract] [Full Text] [Related]

  • 19. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
    Wei C, Yang C, Wang S, Shi D, Zhang C, Lin X, Liu Q, Dou R, Xiong B.
    Mol Cancer; 2019 Mar 30; 18(1):64. PubMed ID: 30927925
    [Abstract] [Full Text] [Related]

  • 20. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
    Yamanashi T, Nakanishi Y, Fujii G, Akishima-Fukasawa Y, Moriya Y, Kanai Y, Watanabe M, Hirohashi S.
    Oncology; 2009 Mar 30; 77(1):53-62. PubMed ID: 19556810
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.